Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Chronic Obstructive Pulmonary Disease
Age: Adult
Dose: Inhaled solution – 175 mcg
Frequency: once daily
Note: Administer by mouth (oral) via nebulizer using a mouthpiece at the same time every day. Not to exceed 175 mg once daily.
Indication: Chronic Obstructive Pulmonary Disease
Age: Adult
Condition: Hepatic impairment
Dose: Inhaled solution – 175 mcg
Note: Mild-to-severe: Safety not evaluated; not recommended in patients with any degree of hepatic impairment.

Child Dose

Clinical InformationAdministration Information
Age: Child
Dose: dosage - No approved pediatric dosage available
Note: No approved pediatric dosage available

Renal Dose

Clinical InformationAdministration Information
Condition: Any degree of impairment
Dose: Not mentioned
Note: No dosage adjustment is required
Indication: COPD
Condition: Severe renal impairment
Dose: Not mentioned
Note: Monitor for systemic antimuscarinic adverse effects
Administration
  • For inhalation only
  • Use with nebulizer
Side Effect

Drug Interaction

Drug NameRisk Factors
Anticholinergic drugs
May have additive effects
OATP1B1 and OATP1B3 inhibitors
May increase systemic exposure of revefenacin's active metabolite

Disease Interaction

Disease NameRisk Factors
No specific contraindications listed
Monitor for general drug reactions

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage

Details coming soon

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.